The UK Competition and Markets Authority’s (CMA) scrutiny of US healthcare REIT Welltower’s acquisition of more than 600 operational UK care homes could become a defining moment for consolidation in the adult social care sector, with lawyers from Browne Jacobson warning that investors will now face far greater scrutiny...
Jeito Capital has reached a major milestone with the final close of Jeito II at €1bn (US$1.2bn), marking the largest fundraise to date for a fully independent biopharma-focused venture fund in Europe. The Paris-based investor has tripled assets under management to €1.6bn in just five years, highlighting growing institutional confidence in Europe’s clinical-stage biopharma opportunity.
Jeito II will continue the firm’s strategy of backing 15–20 high-potential clinical-stage biopharma companies, primarily across Europe, with the ability to deploy up to €150m into a single investment. The strategy is designed to provide...